DCF — ANNE ARUNDEL MEDICAL CENTER INC.
Enterprise Value: $-397.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-397.6M
Enterprise Value
$-138.8M
PV of Cash Flows
$-258.8M
PV of Terminal Value
$-416.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $635.1M | $-17.7M | -3.0% | $-44.6M | $-40.5M |
| Year 2 | $654.2M | $-11.7M | -2.0% | $-39.4M | $-32.5M |
| Year 3 | $673.8M | $-5.3M | -1.0% | $-33.8M | $-25.4M |
| Year 4 | $694.0M | $-2.0M | -0.0% | $-31.3M | $-21.4M |
| Year 5 | $714.8M | $-0.2M | -0.0% | $-30.5M | $-18.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-397.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$616.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.032837857270711354
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5